Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Starbucks Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SBUX
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers SBUX
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sprinklr, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CXM
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers CXM
ROSEN, A LEADING LAW FIRM, Encourages Stellantis N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STLA
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers STLA
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Ipsen provides update on CONTACT-02 Phase III trial in metastatic castration-resistant prostate cancer following final overall survival analysis
From Ipsen Pharma
Via GlobeNewswire
KFSHRC Leads as a Premier Destination for Medical Tourism and Innovative Care Solutions
From King Faisal Specialist Hospital & Research Centre
Via GlobeNewswire
Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging
From Precede Biosciences, Inc.
Via GlobeNewswire
23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial
From 23andMe, Inc.
Via GlobeNewswire
Tickers ME
MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study
From 23andMe, Inc.
Via GlobeNewswire
Tickers ME
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers ABR LFCR ODD SPIR
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers DAVA DXCM MEI OFIX
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Agenus, and ZoomInfo and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers AGEN GTLB ZI
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Starbucks, Sage, Outset Medical, and Super Micro and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers OM SAGE SBUX SMCI
ROSEN, LEADING TRIAL ATTORNEYS, Encourages ZoomInfo Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZI
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers ZI
LIONS GATE ENTERTAINMENT CORP. ANNOUNCEMENT: If You Have Suffered Losses in Lions Gate Entertainment Corp. (NYSE: LGF.A, LGF.B), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers LGF-A LGF-B
EagleView Captures High-Resolution Aerial Imagery and Data of Hurricane Francine at Unmatched 1-Inch GSD, Supporting Immediate Recovery Efforts
From EagleView Technologies
Via GlobeNewswire
Taiwan Tourism’s Brand 3.0 Surges in New York “Taiwan - Waves of Wonder” the New Global Tidal Shift
From Taiwan Tourism Administration
Via GlobeNewswire
ACADIA HEALTHCARE COMPANY, INC. ANNOUNCEMENT: If You Have Suffered Losses in Acadia Healthcare Company, Inc. (NASDAQ: ACHC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers ACHC
Medigene Presents Progress on KRAS Library and UniTope & TraCR Technology at ESMO 2024
From Medigene AG
Via GlobeNewswire
KFSHRC Revolutionizes Patient Care with Pioneering Experience Ambassadors Program
From King Faisal Specialist Hospital & Research Centre
Via GlobeNewswire
Cullinan Therapeutics Presents Positive Updated Data from Module C of Zipalertinib Pivotal Phase 2b Study at ESMO 2024
From Cullinan Therapeutics, Inc.
Via GlobeNewswire
Tickers CGEM
Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Tickers BDTX
Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement of ACR-2316 into Clinic Ahead of Timelines, and Progress on its AP3 Interactome for Proprietary Data Analysis
From Acrivon Therapeutics, Inc
Via GlobeNewswire
Tickers ACRV
NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
From NuCana plc
Via GlobeNewswire
Tickers NCNA
Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer
From Immunocore Holdings plc
Via GlobeNewswire
Tickers IMCR
iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow-up Interim Analysis of GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients
From iTeos Therapeutics Inc.
Via GlobeNewswire
Tickers ITOS
FLUX ALERT: Bragar Eagel & Squire, P.C. is Investigating Flux Power Holdings, Inc. on Behalf of Flux Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers FLUX
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Symbotic, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers CXM EXTR PDD SYM
AVIAT ALERT: Bragar Eagel & Squire, P.C. is Investigating Aviat Networks, Inc. on Behalf of Aviat Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers AVNW
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.